By accessing, browsing, or using the Nitof website ("Website") operated by Hetero Healthcare Limited ("Company"), you ("User") acknowledge that you have read, understood, and agree to be legally bound by these Terms & Conditions ("Terms") and our Privacy Policy. If you do not agree to these Terms, please discontinue use of the Website immediately.
These Terms constitute a legally binding agreement between you and Hetero Healthcare Limited and are governed by the laws of India.
IMPORTANT MEDICAL DISCLAIMER: The information on this Website is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Nitof (Nicotine Transdermal Patch) is a prescription (Rx) product. Always consult a qualified, licensed physician or healthcare professional before initiating, modifying, or discontinuing any medical treatment or therapy.
Specifically:
This Website is intended for:
By using this Website you confirm that:
All content on this Website, including but not limited to text, graphics, logos, product names, images, icons, audio clips, digital downloads, data compilations, and software ("Content"), is the exclusive property of Hetero Healthcare Limited or its content licensors and is protected under:
You may:
You may NOT:
Users agree to use this Website only for lawful purposes. The following conduct is strictly prohibited:
All product information provided on the Nitof Website is consistent with regulatory approvals from the Central Drugs Standard Control Organisation (CDSCO) and complies with:
Promotional material displayed on this Website does not constitute an endorsement for self-medication. Nitof is a Schedule H (Rx) product and must only be dispensed upon a valid prescription from a licensed medical practitioner.
Hetero Healthcare Limited is committed to patient safety. If you experience any adverse drug reaction, unexpected side effect, or product quality issue related to Nitof, please report it immediately through the following channels:
Email: pharmacovigilance@heterohealthcare.com.
Website Contact Form: Write to us.
CDSCO PvPI Portal: https://pvpi.nic.in.
WHO VigiAccess: https://vigiaccess.org
All adverse event reports will be processed and submitted to the National Pharmacovigilance Programme (NPP) at CDSCO as required by Schedule Y of the Drugs and Cosmetics Act and applicable Good Pharmacovigilance Practices (GVP) guidelines.
To the fullest extent permitted by applicable law, Hetero Healthcare Limited and its affiliates, officers, directors, employees, and agents shall not be liable for:
Our total cumulative liability for any claim arising from the use of this Website shall not exceed INR 10,000 (Indian Rupees Ten Thousand Only).
This Website and its content are provided on an "AS IS" and "AS AVAILABLE" basis without warranties of any kind, whether express or implied, including but not limited to:
The Website may contain hyperlinks to external websites, medical databases, regulatory portals, or healthcare information platforms. These links are provided for informational convenience only. Hetero Healthcare Limited:
You agree to indemnify, defend, and hold harmless Hetero Healthcare Limited, its parent company Hetero Group, subsidiaries, affiliates, officers, directors, and employees from and against any claims, liabilities, damages, losses, or expenses (including reasonable legal fees) arising out of or in connection with:
We reserve the right to modify, suspend, or discontinue the Website (or any part thereof) at any time, with or without notice, for maintenance, upgrades, or other operational reasons. Hetero Healthcare shall not be liable to you or any third party for any modification, suspension, or discontinuation of the Website.
These Terms & Conditions are governed by and construed in accordance with the laws of India. Any dispute, controversy, or claim arising out of or in connection with these Terms shall be subject to:
Service Providers
Arbitration
Jurisdiction
All promotional and informational content on this Website is governed by the Uniform Code of Pharmaceutical Marketing Practices (UCPMP) 2024 issued by the Department of Pharmaceuticals, Government of India. We are committed to:
Hetero Healthcare Limited reserves the right to update, revise, or modify these Terms at any time. Changes will be effective immediately upon posting to the Website. Continued use of the Website after any modification constitutes your acceptance of the revised Terms. We recommend reviewing these Terms periodically.
If any provision of these Terms is found to be invalid, unlawful, or unenforceable by a court of competent jurisdiction, such provision shall be severed from the remaining Terms, which shall continue in full force and effect.
No failure or delay by Hetero Healthcare Limited in exercising any right, power, or privilege under these Terms shall operate as a waiver thereof, nor shall any single or partial exercise of any right preclude any other or further exercise of such right.
By using the Nitof website, you confirm that you have read, understood, and agree to be bound by both the Privacy Policy and Terms & Conditions set forth in this document.
© Hetero Healthcare Limited. All Rights Reserved.
© HeteroHealthcare Limited. All rights reserved. | heterohealthcare.com / nitof | For medical queries: consult your registered healthcare provider